「for」の検索結果
118件：81～85件目を表示
-
ochida Pharmaceutical Co., Ltd. Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osak...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -
Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical
preparations-Mytear eye solutions head a diverse line of trusted products Building on a reputation for excellence in ophthalmological drugs, Senju Pharmaceutical has cultivated expertise as a pioneer...
https://www.senju.co.jp/english/about/business/otc.html -
esident: Mr. Naoyuki Mochida; hereinafter: Mochida) and developed by Senju as an eye drop treatment for Dry Eye Disease (DED), has been launched in Japan today. Avarept® represents a novel therapy for...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406.pdf -
2025 General Announcement: Senju Pharmaceutical Co., Ltd. Senju has developed and obtained approval for a BAC-free formulation of Aibeta® combination eye drops Senju Pharmaceutical Co., Ltd. (Head Off...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf -
NewMytear A | OTC Products, etc. | Products | SENJU Pharmaceutical
sium, and calcium was made closer to normal tears. This medicine contains calcium that is important for maintaining the function and transparency of the cornea. pH, osmotic pressure ratio, and viscosi...
https://www.senju.co.jp/english/products/myteara.html